HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?

AbstractBACKGROUND:
Vasopressin plays an essential role in osmoregulation, but has deleterious effects in patients with ADPKD. Increased water intake to suppress vasopressin activity has been suggested as a potential renoprotective strategy. This study investigated whether urine and plasma osmolality can be used as reflection of vasopressin activity in ADPKD patients.
METHODS:
We measured urine and plasma osmolality, plasma copeptin concentration, total kidney volume (TKV, by MRI) and GFR ((125)I-iothalamate). In addition, change in estimated GFR (eGFR) during follow-up was assessed.
RESULTS:
Ninety-four patients with ADPKD were included (56 males, age 40 ± 10, mGFR 77 ± 32 ml/min/1.73 m(2), TKV 1.55 (0.99-2.40) l. Urine osmolality, plasma osmolality and copeptin concentration were 420 ± 195, 289 ± 7 mOsmol/l and 7.3 (3.2-14.6) pmol/l, respectively. Plasma osmolality was associated with copeptin concentration (R = 0.54, p < 0.001), whereas urine osmolality was not (p = 0.4). In addition, urine osmolality was not associated with TKV (p = 0.3), in contrast to plasma osmolality (R = 0.52, p < 0.001) and copeptin concentration (R = 0.61, p < 0.001). Fifty-five patients were followed for 2.8 ± 0.8 years. Baseline plasma and urine osmolality were not associated with change in eGFR (p = 0.6 and p = 0.3, respectively), whereas baseline copeptin concentration did show an association with change in eGFR, in a crude analysis (St. β = -0.41, p = 0.003) and also after adjustment for age, sex and TKV (St. β = -0.23, p = 0.05).
CONCLUSIONS:
These data suggest that neither urine nor plasma osmolality are valid measures to identify ADPKD patients that may benefit from increasing water intake. Copeptin appears a better alternative for this purpose.
AuthorsNiek F Casteleijn, Debbie Zittema, Stephan J L Bakker, Wendy E Boertien, Carlo A Gaillard, Esther Meijer, Edwin M Spithoven, Joachim Struck, Ron T Gansevoort
JournalAmerican journal of nephrology (Am J Nephrol) Vol. 41 Issue 3 Pg. 248-56 ( 2015) ISSN: 1421-9670 [Electronic] Switzerland
PMID25926129 (Publication Type: Journal Article)
Copyright© 2015 S. Karger AG, Basel.
Chemical References
  • Biomarkers
  • Glycopeptides
  • copeptins
  • Vasopressins
Topics
  • Adult
  • Biomarkers (blood, urine)
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate
  • Glycopeptides (blood)
  • Humans
  • Male
  • Middle Aged
  • Osmolar Concentration
  • Polycystic Kidney, Autosomal Dominant (blood, physiopathology, urine)
  • Prognosis
  • Vasopressins (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: